Brent L Saunders

Director; Director, CEO and Chairman of the Board; Director, Chairman of the Board and CEO · 6 filings · Latest: Jun 24, 2026

ARS Pharmaceuticals, Inc.

Bausch & Lomb Corp

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
BLCO	Brent L Saunders	Director, CEO and Chairman of the Board	Mar 6, 2026	Purchase	$17.14	14,700	$252.0K	966,575	Mar 10 8:32 PM
SPRY	SAUNDERS BRENT L	—	May 20, 2025	Proposed Sale	$14.25	120,000	$1.7M	—	May 20 8:48 PM